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ABSTRACT
￿
The intracellular distribution of F-actin and myosin has been examined in mouse
peritoneal macrophages by immunofluorescence microscopy . In resting, adherent cells, F-actin
was distributed in a fine networklike pattern throughout the cytoplasm . Myosin, in contrast,
was distributed in a punctate pattern . After treatment with cytochalasin B (CB), both proteins
showed a coarse punctate pattern consistent with a condensation of protein around specific
foci . When CB-pretreated cells were exposed to opsonized zymosan particles, immunofluores-
cent staining for F-actin and myosin showed an increased staining under particle binding sites .
Transmission electron microscope (TEM) examination of whole-cell mounts of such prepara-
tions revealed a dense zone of filaments beneath the relatively electron-translucent zymosan
particles . At sites where particles had detached during processing, these filament-rich areas
were more clearly delineated . At such sites dense arrays of filaments that appeared more or
less randomly oriented were apparent . The filaments could be decorated with heavy mero-
myosin, suggesting that they were composed, in part, of F-actin and were therefore identical
to the structures giving rise to the immunofluorescence patterns . After viewing CB-treated
preparations by whole-mount TEM, we examined the cells by scanning electron microscopy
(SEM) . Direct SEM comparison of the filament-rich zones seen by TEM showed that these
structures resulted from the formation of short lamellipodial protrusions below the site of
particle binding. Electron micrographs of thin-sectioned material established that these lamel-
lipodial protrusions were densely packed with microfilaments that were in part associated with
the cytoplasmic surface of the plasma membrane . The formation of particle-associated lamel-
lipodia did not appear to represent merely a slower rate of ingestion in the presence of CB,
because they formed within minutes of particle contact with the cell membrane and were not
followed by particle ingestion even after a 1-h or longer incubation . Furthermore, their
formation required cellular energy . These results suggest that cytochalasin B blocks phagocy-
tosis of large particles by affecting the distances over which any putative actomyosin-mediated
forces are generated.
Cytochalasin B (CB)' and related drugs are well-known inhib-
itors of cell motile processes, including particle phagocytosis
(for a review, see reference 9) . Phagocytosis of large particles
'Abbreviations used in this paper : ,t?-ME, ,Q-mercaptoethanol ; CB, cy-
tochalasin B; Fl-Av, fluorescein-avidin ; PBS, phosphate-buffered saline
(20 mM sodium phosphate [pH 7.2]/0.13 M NaCI); Rh-Con A, rho-
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by a variety ofmammalian cell types, including macrophages,
is effectively inhibited in a rapidly reversibly manner by 10-6-
10-5M concentrations ofCB and even lower concentrations of
other cytochalasins (1). The mechanism of action of the cyto-
damine-concanavalin A; TBS, Tris-buffered saline (20mM Tris-HCl-
0.14M NaCl [pH 8.0]) ; TEM, transmission electron microscopy.
373chalasins in vivo remains unclear, although it is generally
agreed that the drug affects the organization of the actin-
containing microfilament system thought to be responsible for
cell motile behavior (1, 9, 17, 32) . Recent evidence obtained in
vitro suggests that the drug binds to the growing ends of F-
actin filaments thereby blocking further G-actin monomer
addition (4, 5, 22, 23) and leading to a net reduction in the rate
of filament growth . It has been suggested that this process if
extended to a dynamic in vivo situation would result in a net
depolymerization of cellular F-actin. This so-called treadmill
model assumes that a cellular process exists for depolymerizing
existing F-actin (4, 22) . This model, however, is not consistent
with a number of electron microscopy studies that show no
drastic decrease in F-actin content in CB-treated cells as com-
pared with controls (1, 10, 20, 29) . In addition, concentrations
of CB required to inhibit actin polymerization per se are
generally higher than that required to block phagocytosis (4, 5,
22,23) .
Other possible mechanisms based largely on in vitro results
have been advanced . Hartwig and Stossel (16) as well as
Weihing (44) showed that CB inhibited the ability of cell
extracts to form cross-linked actin gels at concentrations 10-
fold lower than that required to block phagocytosis. Recently,
Pollard and collaborators (23, 30) have provided evidence that
CB may act directly on actin filaments disrupting inherent
filament-filament interactions and thereby reducing the bulk
polymer strength of the network and affecting the ability to
propagate long-range forces . Stossel and colleagues (17, 25)
have presented evidence suggesting that CB acts to disrupt
network formation by acting directly on actin filaments . These
authors, unlike Pollard and collaborators, present evidence that
suggests that the drug causes a net shortening of filaments (but
not depolymerization) that seriously weakens the strength of
the gel network (17, 25) . The effect of CB on the long-range
strength ofactin gels at physiologically effective concentrations
is, in fact, consistent with several reports that indicate that the
cytochalasins are ineffective in blocking phagocytosis of rela-
tively small particles (14) . Although it may be that the mech-
anism of ingestion of these particular particle types is funda-
mentally different from that operating for larger particles, it
seems possible that a weaker gel network might be capable of
generating enough mechanical work to allow endocytosis of
sufficiently small objects .
We and others have previously found, using immunofluo-
rescent localization techniques, that F-actin (1, 2, 9, 10, 15, 24,
29, 32, 35), myosin (29, 37), and actin-binding protein (37)
appear to concentrate at particle ingestion sites in macrophages .
Apparent accumulation of F-actin (1, 9, 10, 29) and myosin
(29) has been reported at particle binding sites in CB-treated
phagocytes . To more precisely interpret the observed increases
in fluorescent staining associated with these proteins at particle
binding sites, we have studied this process by a variety of
morphologic techniques including correlative light and electron
microscopy procedures (scanning electron microscopy, SEM ;
transmission electron microscopy, TEM) . These studies indi-
cate that, underconditions whereCB inhibits particle ingestion,
lamellipodia containing F-actin and myosin form in an energy-
dependent fashion at the base of the surface-bound particle .
These results suggest that the basic cellular response to particle
binding to the cell membrane is not affected by the cytochal-
asins and further suggest that the effect of the drug is to
interfere with the distances over which actomyosin-generated
forces are transmitted along the cell surface.
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MATERIALS AND METHODS
Preparation of Human Uterine Myosin and Anti-
myostn-heavy-chain Antibodies
Human uterine smooth muscle myosin was prepared from fresh surgical
specimens. Myosin was prepared from such specimens as described by Pollard et
al . (31) . The material was furtherpurified by DEAF Sephadex A-50 as described
by Wang (43).
Uterine myosin heavy chain was purified by preparative electrophoresis as
follows : I mg of DEAE-purified myosin was dissolved in 0.5 ml of4% SDS/I%
f3-mercaptoethanol (8-ME) and boiled for 2 min. The entire sample was applied
to a 3-mm-thick slab gel consisting of a5% acrylamide lower running gel9cm
long and a 3% stacking gel 1 cm long. The two gel layers were prepared as
described by Laemmli (21) . The sample containing l0% sucrose and 0.1%
bromophenol blue was applied to the stacking gel, which was prepared by
omitting the toothed comb so that the sample was applied across the entire gel.
The sample was electrophoresed at 20V(constant voltage) until the tracking dye
reached the end ofthe gel. The gel was stained with Coomassie Blue for 2 h and
destained for 1 h with 10% acetic acid to a degree sufficient to allow the myosin
heavy chain band to be easily seen . The band was excised with a clean razor
blade . After rinsing for 1 h in 100ml of PBS, the gel was homogenized in 10 ml
of PBS with a SorvallOmni mixer (DuPont Co., Wilmington, Del.) equipped
with a microhomogenizer attachment .
1 ml of the homogenate was mixed with I ml of Freund's complete adjuvant
(Difco Laboratories, Detroit, Mich.) and emulsified with theOmni mixer .A goat
wasimmunized by intramuscular injections ofthe emulsionat multiple sites. The
animal was boosted at monthly intervals three times . 10 d after the last injection,
at which time serum samples showed antibodies against native myosin asjudged
by Ouchterlony analysis, theanimal was exsanguinated, and collected serum was
stored at -20°C until further use .
The antimyosin antibodies were then affinity-purified on a Sepharose 4B (4-
ml packed bed) column to which 4 mg of DEAE-purified native myosin had
been covalently attached as described elsewhere (29) .
Extracts of human uterine tissue were prepared as described by Pollard et al .
(31). Washed human platelets were prepared as described by Ginsberg et al. (13)
and were essentially free of erythrocytes and leukocytes, as judged by Giemsa-
stained smears of the final preparation . The cells (750 ug of cell protein) were
washed twice with Tris-buffered saline (TBS) by centrifugation at 3,000rpm for
20 min and the cell pellet was resuspended in 300 pl of 4% SDS/1% S-ME and
placed on a boiling H2Obath for 2 min . Mouse peritoneal thioglycolate-elicited
macrophages were isolated as described (33), and SDS extracts were prepared as
for platelets. These three tissue extracts were applied to l.5-mm-thick 7% SDS
slab gels and electrophoresed for 16 h at a constant voltage of 20 V . The gels
were stained with Coomassie Blue and destained with 10% acetic acid. The gels
were neutralized with phosphate-buffered saline (PBS)(pH 8.0) and stained with
affinity-pure"6I-labeled anti-human uterine myosin heavychain (1 pg/ml at 1.2
pCi/1+g) using a method described by Burridge (7) as modified by Wallach et al.
(42) . Autoradiography wasperformed by placing KodakXR-1 x-rayfilm (Kodak,
Rochester, N. Y.) over the dried gel strips in the presence of an intensifying
screen for the indicated time intervals at -70°C,
The affinity-purified goat anti-human uterine myosin heavy chain antibodies
usedinthe subsequentimmunolluorescence studies were characterized by directly
staining SDS PAGE gel strips with "'I-labeled antibodies according to the
Burridge method (7) . As seen in Fig . 1 (lane 2), the ` 251 antibody predominantly
labels a major Coomassie Blue-staining band of 200-kdaltons (lane 1) in the
crude uterine extract that comigrates with authentic myosin of the parent heavy
chain . This labeling pattern is likewise seen in stained gels of SDS-solubilized
whole human platelets (lane 4) and in SDS-solubilized mouse thioglycolate-
elicited mouse macrophages (lane 6). In the latter two cell types, however, longer
exposure times were required, even though comparable amounts of total cell
protein were initially applied to the gel . In addition, labeling ofa smaller peptide
was observed in platelet extracts andmay represent reaction ofthe antibody with
proteolytic fragments ofmyosinH chain that are commonly seen in extracts (31) .
Quantitative densitometry revealed that the relative reactivity ofthe ' 25I-labeled
antibodies per unit of Coomassie Blue absorbance of the human platelet and
mouse macrophage 200-kdalton peptides was 15 and 5%, respectively, when
compared with the homologous peptide . Thus, the affinity-purified antibodies
made against purified uterine myosin H chains are capable of reacting with H
chains of human platelets and mouse macrophages, and are monospecific by
these criteria.
Fluorescent Reagents
Biotinylated heavy meromyosin (BHMM) was prepared as described by
Heggeness andAsh (18) as modified by Heggeness et al . (19). Fluorescein-avidin(Fl-Av) was purchased from Vector Laboratories, Inc . (Burlingame, Calif) and
used withoutfurtherpurification . Rhodamine-labeled F(ab')2fragmentsofrabbit
anti-goat IgG antibodies were purchased from Cappel Laboratories, Inc . (Coch-
ranville, Pa.) .
Reagents and Chemicals
Paraformaldehyde and redistilled glutaraldehyde were obtained from Polysci-
ences Inc . (Warrington, Pa) . Formaldehyde was freshly prepared from paraform-
aldehyde . CB and zymosan Awere obtained from Sigma Chemical (St . Louis,
Mo .). Acrylamide and bis-acrylamide were obtained from Bio-Rad Laboratories
(Richmond, Calif.). 2-D-Deoxyglucose was purchased from Calbiochem-Behring
Corp. (La Jolla, Calif) .
Macrophage Isolation and Culture
Resident mouse peritoneal macrophages were prepared using BALB-C/St
mice as described previously (33) . The washed cells were allowed to adhere to
16-mm glass cover-slips in culture for 24 h before use . Forwhole-mount TEM
studies (see below) 200-mesh gold grids (Pelco, Tustin, Calif .) coated with
Fotmvar-carbon films were used in place ofcover slips .
Challenge with Opsonized Zymosan Particles
Macrophages mounted either on glass cover slips or on coated gold TEM grids
were pretreated with Tris-Tyrode's bovine serum albumin (BSA) medium con-
taining the indicated concentration of drug inhibitors (ifused) for 15-30 min at
room temperature. Zymosan that had been pretreated with fresh human serum
was added in 10 td of buffer at a concentration of2 x 109 particles/ml to cover
slips(200 tgl) or grids (20 tul) that were oriented cell side up. At various times after
particle addition, excess particles were rinsed away with medium, and the cells
fixed by immediate immersion in fixative. If immunofluorescent analysis was
desired, the cells were fixed subsequently for 20 min with 2% paraformaldehyde/
0.1 M Na-phosphate buffer (pH 7.2) and stained for actin and myosin as
described below . Ifthecells were to be examined by TEM, Ca"-free Karnovsky's
formaldehyde-glutaraldehyde fixative was substituted and, except where indi-
cated, the grids were processed as described below.
Immunofluorescent Staining for F-actin and
Myosin
Formaldehyde-fixed cells mounted on glass cover slips were double-stained
for F-actin and myosin, using the technique of Heggeness et al. (19) as modified
by Painter and McIntosh (29). Briefly, cover slips were treated wtih 0.1% Triton
X-100 in TBS for 2 min, rinsed in BSA-TBS, and stained for 20 min with 100
kg/mlBHMM and 100 tig/ml affinity-purified goat anti-human uterine myosin
heavychain . After thorough rinsing, the cells were counterstained with Fl-Av (50
tug/ml) and rhodamine-labeled F(ab')2 fragments ofrabbit anti-goatIgG.
After washing and mounting in 90% glycerol-TBS (pH 8.0), the cells were
examined with a Zeiss fluorescence microscope equipped with epi-illumination
and filters that allowed the selective viewing of fluorescein and rhodamine. In
preliminary experiments, cells stained with either fluorochromealone were visible
only when the appropriate filter combination was in place . Micrographs were
taken on Kodak Tri-X film using 30-s exposure times. Specificity controls
included addition of 10mM Na PPi to the BHMM staining step or addition of
d-biotin to the Fl-Av step. Both inhibitors oftheir respective reagents completely
blocked cell-associated fluorescein staining but not antimyosin-associated rho-
damine staining . The specificity of the antimyosin reagent was assessed by
preabsorption of the antibody with 10 tug of DEAF-purified human uterine
myosin. No cytoplasmic-associated rhodamine staining was noted after absorp-
tion. In addition, preadsorption had no noticeable affect on BHMM/FL-Av
fluorescein staining . In addition, preimmune goat IgG did not show appreciable
staining when substituted for the goat antibodies .
Electron Microscopy of Whole-cell Mounts
Macrophages were allowed to adhere to carbon-collodion-coated 200-mesh
gold grids, as described above, for 24 h in HEPES-buffered minimum essential
medium containing 5% fetal calf serum (Gibco Laboratories, Inc . Grand Island,
N . Y.), penicillin (100 U/ml), and streptomycin (100 tug/ml) . Such cells were
then subjected to a variety of experimental conditions as described in the
appropriate figure legends.
In electron microscopy experiments where it was desirable to examine speci-
mens stained with BHMM/FI-Av for comparison with immunofluorescence
results, cells were fixed and stained with BHMM/Fl-Av as described above for
FIGURE 1
￿
Antigenic specificity of goat anti-human uterine myosin.
Tissue or cell extracts were dissolved in boiling 4% SDS/1% fl-ME
and applied to 7% SDS acrylamide slab gels . After staining with
Coomassie Blue, each lane was cut out and labeled with 1251-labeled
affinity-purified goat anti-human uterine myosin using the protocol
of Burridge (7) as modified by Wallach et al . (42) . Lane 1, Coomassie
Blue-staining pattern obtained for human uterine extract (110 fig of
protein) ; lane 2, autoradiogram after 6 h of exposure; lane 3, Coo-
massie Blue pattern obtained for human platelet homogenate (105
tLg of cell protein) ; lane 4, autoradiogram after 24 h of exposure ;
lane 5, Coomassie Blue pattern for mouse thioglycolate-elicited
macrophages (95 ug of protein) ; lane 6, autoradiogram after 24 h .
Note the major radioactive band that comigrates with myosin heavy
chain (MHC) . The electrophoretic positions of filamin (F), rabbit
actin (A), and tracking dye ( TD) are indicated by the arrows .
immunofluorescence on indexed gold gridsinstead ofcover-slips. Such specimens
were then fixed with Kamovsky's fixative afterthe lastwashingstep. Afterrinsing
with 0.1 M Na cacodylate buffer (pH 7.4), the grids were incubated for 10 min
at room temperature in 1% OS04-0 .1 M Na cacodylate buffer (pH 7.4) for 10
min. After rinsing with distilled water, we stainedthespecimens with 0.5% uranyl
acetate (pH 4.5) for 2 h and dehydrated them by passing the grids through a
graded series of ethanol-H20 solutions after rinsing them briefly with distilled
H2O . The samples were then critical point dried from Freon 13 inaBomarmodel
SPC-900/EX critical point dryer. All samples for direct comparison were dried
together in a single run . After the specimens were examined in a Hitachi model
HU-12A transmission electron microscope at 120 kV and micrographs were
taken, the specimens were sputter coated with Pt-Au in a Technics West sputter-
coating apparatus (Technics West,San Jose, Calif). Thesame cells were exam-
ined in a Hitachi model HS-500 scanning electron microscope with a tilt stage
angle of 38°and an accelerating voltage of20 kV.
Embedding of cells in situ on cover slips in Epon and thin sectioning was
carried out as described previously (29) . Sections were cut in a plane perpendic-
ular to the cover-slip surface.
Drug Inhibition Protocol
Mouse resident peritoneal macrophages were allowed to adhere and spread
on glass cover slips in 5% fetal calfserum/Dulbecco's minimum essentialmedium
for 4 h before use . After rinsing with Tyrode's containing 0.25% BSA, the cells
were incubated in a given drug at the indicated concentrations for 15 min before
challenge with opsonized zymosan. Cells were exposed to zymosan for 30 min in
the continued presence of the drug. The specimens were immediately fixed with
2% formaldehyde in 0.1 MNa phosphate buffer (pH 7.4) for 20 min. Reversal of
any observed inhibitory effects was tested by rinsing the cover slip withdrug-free
media to remove excess drug and particles, followed by incubation in drug-free
medium for 30 min .
Immunofluorescent Staining for Actin and
Quantitation of Results
After fixation, cells mounted on cover slips were stained for actin using
BHMM and Fl-Av as described above. To quantitate the actin response to
particle binding tothe cell surface, at least 200cell-bound particles wereexamined
at random by immunofluorescence microscopy and scored for the presence ofan
increased amount of F-actin-associated fluorescence associated with the particle
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375binding site as compared with surrounding regions of the cell cytoplasm. Several
initialexperiments wereperformed using a double-blind protocol andgaveresults
comparable to conventionally collected data. Most of the experiments reported
were not done blind, because with experience it became relatively easy for an
experienced observer to distinguish drug-treated samples from controls . All
results represent themean of three or more separate experiments.
Particle Ingestion Assay
After the cells had been fixed with 2% formaldehyde/0 .1 M Na phosphate
buffer (pH 7.2), ingestion of zymosan was assayed as described previously (29)
by counting in the microscope the number ofcell-bound particles notstained and
therefore not accessible to rhodamine-concanavalinA (Rh-Con A) (20 I+g/ml) .
At least 200 particles were counted . Staining for actin wasdone after the cells
had been treated with 0.1% Triton X-100 in TBS. Particles unstained by Rh-Con
Awere presumed tobe within the cell. Partialstaining ofparticles in a crescenthke
pattern was also seen, indicating partial ingestion. These particles were not
counted as ingested. In all cases where drugs were found to inhibit ingestion by
the above criteria, no such partial or crescent forms were observed . The actin
staining pattern associated with the bound particles in general was greatly
enhanced in intensity as compared with surrounding cell regions and was
associated with regions ofthe particle in direct contact with the cell surface. All
data are themean of three separate experiments . Under normal assayconditions,
30-40% of the cell-bound particles were inaccessible to Rh-Con A. If such
preparations were made permeable to Rh-Con Aby treatment with 0.1% Triton
X-100 before staining, all observable zymosan particles were brightly stained . In
addition, all particles were accessible to Rh-Con A in presence of inhibitors of
phagocytosis (see Results) .
RESULTS
The Effects of CB on Actin and Myosin
Distributions in Macrophages Exposed to
Zymosan
Macrophages pretreated with CB (10 Ntg/ml) showed dra-
matic changes in the cytoplasmic distribution of actin and
myosin as revealed by immunofluorescence (Fig. 2) . Actin was
initially distributed in a diffuse pattern (Fig . 2A) with the
myosin distributed in a relatively coarse punctate pattern (Fig .
2 B), confirming our previously reported results (29) . Treatment
with CB for as little as 5 min at room temperature resulted in
the actin and myosin patterns seen in Fig . 2C and D, respec-
tively . The actin patterns assumed a coarse, coagulated pattern
relative to that seen in untreated cells with the myosin patterns
partially superimposed on the actin staining pattern . This
pattern was not seen in controls even at the thinnest peripheral
regions of spread cells where superposition of fluorescence was
not a significant factor . Thus this pattern was not a result of
CB-induced flattening of the cell caused by spreading .
When cells pretreated with CB for 15 min were exposed to
zymosan for 30 min, increased staining for both actin (Fig . 3A)
and myosin (Fig. 3 B) was found under the bound particles in
FIGURE 2
￿
Simultaneous immunofluorescent localization of actin and myosin in resident mouse macrophages. (A) Actin-staining
pattern (ac) obtained for a normal adherent mouse macrophage . (B) Myosin-staining pattern (my) in the same cell . (C) Actin-
staining pattern (ac) obtained after treating the adherent cells with cytochalasin B (10yg/ml) for 30 min at room temperature
before fixation and staining as described in Materials and Methods. (D) Myosin (my) distribution in the same cell . In all cases,
macrophages were allowed to adhere to cover slips for 24 h in complete medium at 37°C before the experiment . The adherent
cells were then treated with Tyrode's BSA (200 ftl) with (lower pair) or without (upper pair) CB for 30 min. The cells were
immediately fixed with 2% paraformaldehyde and double-stained with BHMM/FI-Av and goat antimyosin/rhodamine-labeled
rabbit anti-goat F(ab')2 fragments for actin and myosin, respectively . Bar, 10 ttm. X 1,250.
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The actin distribution was relatively uniform whereas the
myosin distribution was patchy . Fluorescence associated with
both proteins was concentrated in a plane of focus that was
below the cell-bound particle. Treatment with up to 100,ug/ml
CB for as long as 30 min gave similar results (not shown) .
Removal ofCB by washing after 15-min exposure to zymo-
san resulted in immunofluorescent patterns that were indistin-
guishable from that obtained in non-drug-treated macro-
phages, showing that the process was completely reversible
even after the stimulus and the cell surface had been in contact
for up to 30 min before drug removal (Fig. 3 C and D). It is
important to note that, in the absence of the drug, the most
intense staining observed was in the plane of focus of the
zymosan particles . Thus, this staining is presumably associated
with pseudopod extension in this case .
Quantitation of the Effect of CB on Zymosan
Ingestion and the Particle-associated Actin
Response
It seemed possible that the oval-shaped actin- and myosin-
rich zones associated with bound zymosan in CB-treated cells
could represent incomplete inhibition of ingestion attributable
to a reduction in the rate of ingestion alone . To evaluate this
possibility, we measured the percentage of bound particles
ingested in the presence and absence ofCB . This was done by
determining the ability ofRh-Con A to label surface particles
in fixed but intact cells. To visualize the actin distribution
associated with surface and ingested particles, the cells were
made permeable after Rh-Con A staining and stained with
BHMM/Fl-Av . A typical result is shown in Fig. 4 . In non-
drug-treated controls, completely ingested zymosan is essen-
tially unstained by Rh-ConA (Fig . 4A, solid arrow) ; this same
particle showed intense staining for actin (Fig . 4 B, solid arrow).
Unexpectedly, particles that were apparently only partially
ingested were seen (Fig . 4A, dashed arrows) . Those areas of
the particle surface that were inaccessible to Rh-Con A were
strongly stained by BHMM/Fl-Av (Fig. 4B, dashed arrows) .'
In contrast, in cells treated with CB (10 pg/ml), bound
zymosan particles were completely accessible to Rh-Con A
(Fig . 4 C), and most particles had typical oval-shaped regions
of actin-associated staining in a focal plane below that of the
particles (Fig . 4D). In addition, the dimensions of the actin
pattern were significantly less than the particle outline as
revealed by Rh-Con A (compare Fig. 4C and D), indicating
that the actin response was not attributable to substantial
pseudopod formation.
Conceivably, CB could merely slow the rate of pseudopod
extension around the zymosan particles. Using the Rh-Con A
technique to measure ingestion, the percentage of totally in-
gested particles was determined in the presence and absence of
CB as a function of time of exposure to particles . As docu-
mented in Table I, no particles were observed that were com-
'The inability ofRh-Con A to penetrate membrane-particle interfaces
is of interest with respect to the mechanism of release of lysosomal
enzymes during phagocytosis . It has been suggested that release of
lysosomal enzymes (some of which are comparable to Con A in
molecular weight) into the medium can be explained by lysosomal
fusion with phagosomes that are not yet closed to the extracellular
space (45) . If this is true, it is somewhat difficult to explain why the
particle-membrane interface is not accessible to Rh-ConA.
pletely ingested even after 2 h ofincubation, even though >60-
80% ofthe bound particles had demonstrable oval-shaped actin
stain in pattern associated with them . Furthermore, no partial
ingestion profiles were noted . Control cells, in contrast, com-
pletely ingested up to 40-50% of bound particles in the same
time period .
In our experience, the Rh-Con A technique can easily detect
ingestion of at least 25% of any given individual particle. Thus,
within these limits, we found no evidence to suggest that CB
acted by merely slowing the rate of ingestion.
Correlative TEMandSEM of Whole Mounts of
CB-treated Macrophages Exposed to Zymosan
To gain higher-resolution morphological information, we
FIGURE 3 Effect of CB on actin- and myosin-staining patterns at
zymosan-binding sites. Patterns of staining with (A) actin (ac) and
(B) myosin (my) in the same cell, which had been pretreated with
CB (10 Ag/ml) for 15 min, then exposed to opsonized zymosan for
15 min before fixation and staining . Zymosan-binding sites are
associated with oval-shaped zones of fluorescence seen with both
fluorochromes (upper arrow) . These zones are in a focal plane that
lies below that of the bound particles . The larger zone of staining
(lower arrow) is a site associated with a clump of zymosan particles .
Note that the condensed actin- and myosin-staining patterns in
those regions of the cell not associated with particles are quite
similar to those seen in CB-treated cells not exposed to zymosan, as
shown in Fig . 2 C and D. (C) Actin and (D) myosin distribution in
a CB-treated cell that had been exposed to zymosan for 15 min in
the presence of drug and then incubated in drug-free media for 15
min before fixation and staining . Unlike panels A and B, the plane
of focus is through the zymosan particles and thus above the main
cell body . Bar, 10Am . x 1,125 .




377performed TEM analysis ofwhole mounts of CB-treated mac-
rophages on carbon-coated gold grids . Initial attempts to ex-
amine the ultrastructural elements associated with zymosan
binding sites in glutaraldehyde-fixed cells (using methods de-
scribed by Wolosewick and Porter [47]) were complicated by
the inability of the electron beam to completely penetrate the
adherent particles . In the course of our immunofluorescence
localization studies, however, we noticed that -25-30% of the
actin- and myosin-rich oval-shaped zones seen in CB-treated
cells exposed to zymosan were not associated with a particle .
Because of their similarity in shape to that of the stained zone
seen to underlie the majority ofparticles in such cells (and also
because these structures were seen only after exposure to
zymosan), we suspected that such sites represented areas where
bound particles had been lost during staining.
To explore this possibility, a premarked field of such a
preparation of cells was examined by phase microscopy before
and after actin staining. In Fig. 5, several sites are seen (arrows)
where zymosan has been lost during staining. As expected,
sites at which particles were previously attached showed clear
zones of actin staining.
Because particles were absent from a proportion (-25% of
that associated with zymosan after staining [Table I]) of actin
accumulation sites, we next examined the ultrastructural char-
acteristics of such regions that were stained with BHMM/Fl-
Av by whole-mount TEM .
Fig. 6 shows the results obtained when CB-treated and
zymosan-exposed cells were fixed with formaldehyde and
stained with BHMM/Fl-Av after Triton X-100 treatment . The
overall morphological appearance of the transparent cell areas
FIGURE 4
￿
Relationship of degree of particle phagocytosis to the cytoplasmic actin distribution . After exposure to xymosan particles
for 30 min in the absence (upper panels) or presence of CB (10 ftg/ml, lower panels), cells were fixed and stained with Rh-Con A .
After washing, the cells were made permeable with Triton X-100 and stained for actin (A and C . Note in controls (A and B) that
particles in various stages of engulfment are seen ranging from complete ingestion (solid arrows) to partial ingestion (dashed
arrows) and that the cytoplasmic actin-specific staining is associated with the membrane-particle interface (upper panels) . No
such ingestion profiles are seen in CB-treated cells (lower panels) . Note that panels A- C are focused in the plane of the particle ;
D is focused in a plane just below the bound particles. Bar, 10 Jim . x 1,250.
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fixed controls (not shown), indicating that the immunofluores-
cent staining procedures did not produce any gross morpho-
logical artifacts . In CB-treated cells exposed to zymosan, sites
that were previously associated with particles showed a dense
network of filaments that underlie former particle binding sites
(Fig. 6C and D) . A similar oval-shaped zone of filamentous
material is seen beneath the relatively translucent zymosan
particle seen in Fig . 6B, indicating that the structures seen in
Fig . 6 C andD were not caused by particle detachment .
Comparison of filament diameters measured at random in
these BHMM/Fl-Av preparations (Fig . 7A) with those mea-
sured in formaldehyde-fixed but unstained preparations (Fig .
7 B) showed an increase in diameter from -50 A in the controls
to 200 A in the BHMM-treated samples, which was presumably
the result ofBHMM and Fl-Av binding to the filaments . This






* Macrophages on cover slips were preincubated at room temperature with
CB (10fig/ml) orDMSO (0.1%) for 15 minand opsonized zymosan (Zy) was
added (40 Zy/cell) in a total volume of 200 fil of Tyrode's BSA medium .
Cover slips (in duplicate) were fixed at the indicated times with 2% form-
aldehyde/0 .1 M Na phosphate (pH 7.4) for 20 min . After fixing, the cells
were assayed under the microscope for total zymosan bound per cell,
percent ingestion, and percent of particles showing a discernible increase in
particle-associated actin as described in Materials and Methods . Results
represent an average of three separate experiments . ND, not determined .
apparent increase in filament diameter appeared to be medi-
ated by BHMM, because the control was treated with BSA and
Fl-Av . Thus, these structures appear to correspond to the actin-
containing regions revealed by immunofluorescence.
The grid matrix position of the cell shown in Fig . 6 was
noted, the specimen subsequently sputter coated with Pt-Au,
and the same cell as seen in Fig . 6 examined by SEM . This
approach revealed, as can be seen in Fig. 8, that the dense oval-
shaped zones of filaments seen in these stained cells were
identical to regions where rather stubby lamellipodia (arrows)
had formed, presumably as a result ofparticle-cell interactions.
This can best be seen by direct comparison of Figs . 6 and 8 .
Thus, the oval-shaped actin- and myosin-associated fluorescent
zones detected by immunofluorescence are identical to these
lamellipodial structures and form only after interaction of
zymosan with the cell surface .
TEM of Oriented Thin Sections
To determine whether the lamellipodia-like structures seen
in CB-treated cells after exposure to zymosan were artifacts
arising from the immunofluorescent staining procedures em-
ployed, CB-treated cells were fixed with Karnovsky's glutar-
aldehyde-formaldehyde fixative after exposure to zymosan for
15 min. These cells were embedded in situ in Epon and thin
sectioned in a plane perpendicular to the substratum .
As seen in Fig . 9, CB-treated cells clearly show zones of 70-
Amicrofilaments that appear to contact the cytoplasmic mem-
brane surfaces including plasma membrane surfaces in contact
with zymosan and intracellular vacuoles (arrows) . These fila-
ment-rich regions were usually associated with slight protru-
sions ofthe overall cell surface that could best be described as
rather stubby pseudopods. These structures on average ranged
from 0.2 to 0 .3 t,m in length and were usually found to lie
within the particle periphery . After extended incubation times
of up to 2 h, the structures did not grow in length or appear to
advance around the surface of the particle (not shown) . Thus,
the lamellipodial structures observed by SEM of immunofluo-
rescently stained cells are demonstrable in well-fixed and thin-
sectioned cells and contain microfilamentous structures .
FIGURE 5
￿
Immunofluorescent localization of F-actin at sites of particle loss in CB-treated macrophages exposed to zymosan. A
predetermined and marked field of cells, which had been exposed to zymosan after CB treatment as in Fig . 3, was photographed
immediately after formaldehyde fixation, using phase-contrast optics . Thespecimen wasthen stained as usual for actin as described
in Materials and Methods. After relocating thesame field of cells, the phase-contrast image (middle panel) andthe actin-associated
immunofluorescence (right panel) were photographed . As indicated by the arrows, several zymosan particles have been lost as a
result of staining . As shown by the right panel, these sites show regions of actin-associated immunofluorescence that are
indistinguishable from sites with associated zymosan. x 920.
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15 1 .2 4 85
30 7.4 27 90
60 8.3 45 88
120 9.6 51 ND
15 0.8 <0.5 80
30 5.1 <0.5 75
120 6.2 <0 .5 82Effect of Metabolic Inhibitors on Formation of
Particle-associated Lamellipodial Structures in
CB-treated Macrophages
Table II shows the effect of metabolic inhibitors on the
formation of actin-containing lamellipodia . As assessed by
immunofluorescence, 10 mM NaN3 completely and reversibly
blocked the formation of the oval-shaped actin-containing
structures in CB-treated or non-CB-treated macrophages . As
expected, no detectable ingestion of zymosan was noted in the
presence of either CB or azide alone.
In addition, the actin-rich lamellipodial structures preformed
in CB-treated cells are present even after 30 min of incubation
in CB-free NaN3 medium (Table II; line S) . Because lamelli-
podia do not form in the presence of NaN 3 (Table II ; line 6),
this result indicates that the lamellipodia formed in CB-treated
cells after particle contact with the cell are stable structures that
persist for at least 30-60 min.
FIGURE 6
￿
Transmission electron microscopy of CB-treated macrophages exposed to zymosan and stained for actin with BHMM/
Fl-Av . (A) Low-magnification micrograph of a CB-treated macrophage that had been exposed to zymosan and subsequently
stained for actin by use of the Heggeness and Ash technique (18) . After staining, the specimens were postfixed with Karnovsky's
fixative and processed as described by Wolosewick and Porter (47) . This cell shows an example of a particle that was sufficiently
electron transparent to show an outline of an underlying filamentous network (dashed arrows) and two sites where particles were
lost during processing . These sites are shown at higher magnification in panels e through D as indicated by the bracketed areas .
Note in panel 8 the filamentous zone underlying the zymosan particle (arrow) . (A) Bar, 5Am . x 3,600. (B-D) Bars, 0.2 jim . x 27,000.
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The major finding of this work is that particle binding to
macrophage surfaces induces rapid and energy-dependent for-
mation of actin- and myosin-containing lamellipodia at the
particle base in the presence ofconcentrations ofCB sufficient
to block particle ingestion . The lamellipodia formed after
particle contact are similar to true pseudopods formed in non-
CB-treated cells in that they contain both major contractile
proteins and their formation appears to require metabolic
energy (Table II). However, they do not merely represent a
slower rate of pseudopod advancement around the particle
surface, because they form within minutes of particle contact
and do not appear to advance further even after 2 h of
incubation .
The Association of Actin and Myosin with
Particle-induced Lamellipodial Structures
The presence of F-actin in CB-treated cells is well-docu-
mented (1, 9, 10, 29, 32) . The present work is in agreement and
further shows that particles capable of activating the contractile
apparatus induce the accumulation of actin filaments at their
sites of binding in cells pretreated with CB . The evidence that
these filaments are, in fact, F-actin is based on their morpho-
logical appearance and, more significantly, their ability to bind
heavy meromyosin (Figs . 3 and 7), a reagent that is specific for
the filamentous form of actin but not for G-actin (27) . 3
A variety of evidence suggests that at least a fraction of the
particle-associated actin appears to be associated physically
with the cytoplasmic face of the membrane . For example, Fig.
9 shows 50- to 70-A filaments that appear to make close contact
with the membrane . In fact, membranes associated with 1-,um
latex particles isolated in our own laboratory contain F-actin
and myosin as assessed by immunofluorescent staining and by
SDS PAGE. Furthermore, the amount of actin associated with
these membranes per unit of membrane protein was not de-
tectably different when normal phagosomes were compared
with latex-associated membranes obtained from CB-treated
cells (R . G . Painter, unpublished observations) . Thus, actin
sThis interpretation assumes that HMM binds only to F-actin and no
other cellular proteins . The validity of this interpretation is supported
by the fact that sodium pyrophosphate blocks the observed fluorescent
patterns in areas that correspond to filament-rich zones observed in
TEM.
FIGURE 7 Comparison of whole-cell mounts
by TEM before and after staining with BHMM/
Fl-Av . (A) A micrograph of the BHMM/FI-Av-
stained preparation . (8) A sample identical in
preparation to that seen in A, except that stain-
ing with BHMM wasomitted . Accelerating volt-
age, 125 kV . Bars, 0.2wm . x 48,000 .
filaments appear to be, in part, associated with particle mem-
brane binding sites, both in normal and in CB-treated cells, a
fording that is similar to reports about a variety ofcell systems
that demonstrate actin in association with the plasma mem-
brane and isolated surface receptors (3, 8, 12, 28, 34) .
Myosin is also present in lamellipodia formed at particle
membrane binding sites in CB-treated cells. The presence of
the two major force-generating proteins of contraction in ap-
parently high concentrations in lamellipodial structures raises
the possibility that the formation ofthese structures was caused
by a localized actomyosin contraction . This possibility is sup-
ported by a number offacts. First, the morphologic appearance
of the forming lamellipodia in relation to the shape of the
particle (Figs. 6 and 8) suggests that membrane immediately
adjacent to the particle contact point (not periphery) has
pleated in a direction parallel to the particle perimeter . This
suggests that radial forces running parallel to the cell mem-
brane surface have pulled the adjacent membrane surface, to
which the filaments are attached, toward the particle. Second,
formation of the lamellipodial structures was blocked by met-
abolic poisons such as NaN 3 , which is consistent with an
actomyosin-mediated contraction.
The Relationship between Particle-induced
Lamellipodium Formation and Normal
Pseudopod Formation
The lamellipodial structures that formed in CB-treated cells
upon particle contact resemble, in some respects, pseudopods
formed in control cells. Like lamellipodia, pseudopods contain
actin filaments (1, 2, 9, 15, 29, 32, 35) and myosin (29, 37) and
form in response to membrane contact with appropriate parti-
cle surfaces . In addition, the metabolic requirements for the
formation of both structures are similar . These pseudopodlike
structures were not attributable to a reduction in the rate of
particle engulfment in the presence of the drug, because they
formed rapidly and did not show further growth even after 2
h of incubation. These similarities lead us to propose that
lamellipodia seen in CB-treated cells are shorter, less extensive
analogues ofpseudopods seen in control cells and thus represent
an abortive form of phagocytosis . A major prediction of this
concept is that the ability ofCB to inhibit phagocytosis would
be dependent on the size and geometry of the particle . Several
reports have presented data that support this prediction . Thus,




381CB did not block ingestion of Chlamydia psittaci, a microor-
ganism of <0.6 Itm in diameter (14) . In addition, CB, while
blocking complete ingestion oflarger organisms such as E . coli
K12 (10), did not prevent formation of microfilament-rich
pseudopods that partially surround the surface-bound particle
(24) . Our own preliminary results show that ingestion of latex
particles of 0 .6 pin and smaller is unaffected by CB at concen-
trations of up to 100 )Ag/ml as judged by electron microscope
examinations of thin sections (R. G . Painter, unpublished
observations) . CB has no apparent inhibitory effect on a num-
ber of endocytotic processes, including endocytosis of small
bacteria (14), absorptive pinocytosis (46), and endocytosis me-
diated by coated pits (46). It is interesting to note that in those
cases where fluid-phase pinocytosis has been reported to be
inhibited by CB, uptake was mediated by vesicles 1 lAm or
larger (41), a result entirely in agreement with our hypothesis .
Significantly, Taylor et al . (39, 40) have recently shown that
fluorescein-labeled actin microinjected into cultured cells be-
comes localized at sites of pinocytosis and endocytosis . Fre-
quently, lack of inhibition ofendocytosis byCB has been taken
to imply that there exists a mechanism entirely different from
that ofphagocytosis (14, 44, 34) . In view of these and ourown
results, we support the view (9, 10, 24, 29, 35) that evidence
other than lack of inhibition by CB would be required before
one could conclude that a given endocytic process is not
mediated by microfilaments, at least in those cases where
endocytosis of structures smaller than 0 .5 pin is concerned .
Implications for the Mechanism of CB Inhibition
of Phagocytosis
The cytochalasins areknown to have at least two possible in
vitro effects on F-actin. First, the drug inhibits actin polymer-
ization (4, 5, 17, 22, 23, 30) by blocking monomer addition at
the barbed end ofgrowing filaments (23, 30) . Blocking one end
of the filament would also inhibit treadmilling of actin (4, 22) .
Second, the drug appears to affect bulk gel strength by blocking
direct filament interactions (23, 30) and/or by reducing the
length of F-actin filaments (17, 25) . Both effects would be
expected to drastically alter the overall bulk strength of the
cytoplasmic gel . The results obtained here indicate that lamel-
lipodia form in CB-pretreated cells in response to particle
FIGURE 8
￿
Scanning electron micrographs of the same cell as shown in Fig . 6 after sputter coating with Pt/Au . The panels labeled
A-D correspond to identical areas visualized by transmission electron microscopy in Fig . 6 . Note the lamellipodia-like outcroppings
of the cell surface in panel A (bracketed areas labeled Cand D), which are seen at higher magnification in panels Cand D. These
lamellipodia correspond to the filament-rich zones seen in the corresponding panels in Fig . 6 . Also, note the lack of pseudopodial
extensions at the edge of the zymosan particle (panel B) . (A) Bar, 5Am . x 3,300 . (9- D) Bars, 0.2 tLm . x 16,500.
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￿
An electron micrograph of an oriented thin section of a CB-treated macrophage exposed to zymosan . Adherent CB-
treated (15 min) macrophageswere exposed to opsonized zymosan (Zy) for 15 min, fixedwith Karnovsky's fixative, andembedded
in situ in Epon . Specimens were thin sectioned perpendicular to the substratum . Note the thin filaments (50-70 R) that appear to
make contact with thecytoplasmic face of the plasma membrane (arrows) and are contained within fingerlike protrusions of the
membrane surface . x 112,000 .
TABLE II







2. CB, 10 ttg/ ml
3 . CB
4 . NaN3, 10mM
5 . CB
6 . NaN3 + CB
7. NaN3 + CB
" Macrophages on cover slips were preincubated with the drug indicated in
the first column ( Treatment 1) for 15 min at room temperature . Opsonized
zymosan (Zy) wasadded at a ratio of 20 Zy/Cell and incubation continued
for 30 min . After a brief rinse in drug-containing medium, cells were
incubated in 200 AI of Tyrode's BSA containing the drug listed under
Treatment2 for 30 min. The reaction was terminated by fixing the cells with
2% formaldehyde/0.1 M Na phosphate (pH 7.4) for 30 min. The percent of
ingested particles was determined under the microscope by the Rh-Con A
accessibility method as described in Materials and Methods. The percentage
of particles with a discernible actin-staining pattern similar to that seen in
Fig . 3 was taken to indicate formation of actin-containing lamehipodia . At
least200 particles per determination were scored, results represent the mean
of three separate experiments .
binding . These structures apparently formed in the drug's
presence and appeared to be densely packed with F-actin
filaments as judged by their ability to bind HMM and by
morphological criteria. It is not possible to ascertain whether
these filaments were newly formed by polymerization or were
recruited in the form of intact filaments from other regions of
the cytoplasm . In spite of this, the data in Table I show that,
once formed, lamellipodia may persist in the presence of CB
for as long as 2 h . Thus, the lamellipodial actin filaments
appear to be stable over a substantial period of time in CB .
This suggests thatCB does not act on macrophages by decreas-
ing the number of actin filaments and that certain types of
actin-containing microfilaments are not turning over rapidly in
vivo . If the filaments were turning over either by treadmilling
or by bulk polymerization/depolymerization, CB might be
expected to alter the filament number . Both the resistance to
CB and the stability of the lamellipodial filaments may arise
because these filaments are attached to the plasma membrane
at their barbed end, like the actin filaments in other cells (6,
11, 26, 36) . Such filaments anchored to membrane sites might
be resistant to the action ofCB .
In view of the above considerations, our data with respect to
phagocytosis are best explained by a CB effect exerted on
localized gel-sol transformations, especially because the in vivo
effects that we see occur in a range of drug concentrations that
is similar to those required for the effects of the drug on bulk
gel strength in vitro.
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